A new study identifies metabolites in blood as potential early warning signals for diabetes and kidney disease.
The study, published in the Journal of Proteome Research, was conducted by researchers from IIT Bombay, Osmania Medical College, and Clarity Bio Systems.
Researchers analyzed blood samples from 52 individuals using dried blood spots and found distinct metabolic patterns.
The study identified 26 metabolites that differed significantly between healthy individuals and those with diabetes.
India has over 100 million people with diabetes and another 136 million classified as pre-diabetic.
Detailed Insights:
Metabolomic profiling allows for the detection of subtle changes in the body’s chemistry that may precede disease, enabling early intervention and prevention of complications.
The study revealed two distinct subgroups among diabetics, one with metabolic profiles closer to healthy individuals and another showing pronounced changes in markers related to stress, inflammation, and energy metabolism.
Early detection tools like metabolomic profiling could be transformative in India, where more than 80% of people with NCDs remain undiagnosed or inadequately treated.
If validated in larger studies, metabolomic markers could be used to develop low-cost, field-friendly tests for early screening, especially in rural and underserved areas, using dried blood spots for easy sample collection.
Personalized care could be enabled through metabolomic profiling, allowing doctors to tailor interventions based on individual risk by grouping patients based on their metabolic profiles.
Scientific/Technical Concepts Involved:
Metabolites: Small molecules produced during metabolic processes in the body, reflecting the state of various organs and systems.
Metabolomic profiling: The large-scale study of metabolites to detect subtle changes in the body’s chemistry that may precede disease.
Liquid chromatography and mass spectrometry: Advanced techniques used to analyze hundreds of metabolites from a single blood sample.